Onconic Therapeutics Inc. (KOSDAQ:476060)

South Korea · Delayed Price · Currency is KRW

23,500

+450 (1.95%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2022	FY 2021
Period Ending	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Biotechnology	95.00M	60.00M
Biotechnology Growth	58.33%	-
Total	95.00M	60.00M
Total Growth	58.33%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2022	FY 2021
Period Ending	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
South Korea	95.00M	60.00M
South Korea Growth	58.33%	-
Total	95.00M	60.00M
Total Growth	58.33%	-

Source: S&P Global Market Intelligence.